FORTIS MEMORIAL RESEARCH INSTITUTE
🇮🇳India
Clinical Trials
5
Active:0
Completed:0
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Radiation- Induced Alopecia in Patients Undergoing Radiation Therapy to the Brain
Terminated
- Conditions
- Alopecia; X-Rays
- First Posted Date
- 2018-06-01
- Last Posted Date
- 2019-03-04
- Lead Sponsor
- Fortis Memorial Research Institute
- Target Recruit Count
- 25
- Registration Number
- NCT03543020
- Locations
- 🇮🇳
Department of Radiation Oncology, Fortis Memorial Research Institute, Gurgaon, Haryana, India
News
Oman Achieves Medical Milestone with First Successful CAR-T Cell Therapy Implementation
The University Medical City in Oman successfully implemented the first CAR-T cell therapy in the Sultanate, positioning the country among regional leaders in advanced blood cancer treatment.
Dostarlimab Achieves 100% Remission in Small-Scale Colorectal Cancer Trial
A groundbreaking clinical trial at Memorial Sloan Kettering Cancer Center reported complete remission in all 18 patients with mismatch repair-deficient colorectal cancer after six months of dostarlimab treatment.